News

Industry veteran Warren Jeffery to retire

BY Michael Johnsen

EDMONTON, Alberta — Katz Group Canada on Monday announced the planned retirement Oct. 31 of Warren Jeffery, chief development officer and interim chief merchandising officer.

“We thank Warren for his contributions and his leadership,” stated Andy Giancamilli, CEO of Katz Group Canada. “Warren has been at the helm of key organizational initiatives that have driven innovation in pharmacy care and improved medication compliance and has set a solid foundation for future organizational growth. We wish him all the best in his retirement.”

Jeffery’s career spans 35 years. He joined Rexall with a mandate to strengthen Rexall’s corporate store operations and has since helped Rexall to significant gains in store capabilities, strategies and processes that span operations, real estate, acquisitions and pharmacy services. Jeffery played a key part in the rollout of more than 200 prototype stores, the development of progressive employer‐based and specialty programs, and the launch of Rexall Reminder Ready, a first-to-market medication compliance program.

Most recently, Jeffery was the executive sponsor for Rexall’s innovative healthy living prototype.

“There is a strong management team at Rexall and a genuine dedication to improving patient care and delivering a superior customer experience," Jeffery said. "I am appreciative of the role I’ve played in the organization’s development.”

Jeffery had previously served in senior executive roles in operations, merchandising and marketing at several retail pharmacy organizations, including Perry Drug Stores, Revco Drug Stores, Phar‐Mor Deep Discount Food & Drug and McKesson. Jeffery holds a pharmacy degree from Ferris State University in Big Rapids, Mich.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Study: Some parents of young kids opt for alternative vaccination schedule

BY Allison Cerra

ANN ARBOR, Mich. — According to new research conducted by the University of Michigan, more than 1-out-of-10 parents of young children use an alternative vaccination schedule, a practice that may put children’s health at risk.

“Small decreases in vaccine coverage are known to lead to dramatic increases in the risk of vaccine preventable disease outbreaks,” said Amanda Dempsey, study author, assistant professor in the department of pediatrics and communicable diseases and a member of the Child Health Evaluation and Research Unit at C.S. Mott Children’s Hospital. “Not following the recommended schedule leaves kids at risk for these diseases unnecessarily.”

When it came to who developed the alternative schedule, 41% of the parents said they developed it, 15% said a friend developed the schedule, and 8% reported using a well-known alternative schedule developed by a pediatric expert (i.e., Dr. Bob Sears). What’s more, nearly one-third of parents (30%) said they had initially followed the recommended vaccination schedule, but many said they switched because it “seemed safer.”

The most commonly-delayed vaccines were measles-mumps-rubella (45%) and diphtheria-tetanus-acellular pertussis (43%).

Among those parents that adhered to the regular vaccination schedule, 25% said they thought that delaying vaccination was still safer.

The study, which was published in Pediatrics, surveyed 771 parents of children ages 6 months to 6 years during May 2010.

Dempsey also noted that an alternative vaccination schedule potentially could lead to "underimmunizaton," which could put children’s health at risk.

“More resources need to be devoted to finding ways to successfully change where attitudes are going,” Dempsey said. “Clearly, this problem is not going to go away, and our data suggest it will actually get worse over time.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Kodak introduces limited-edition, Susan G. Komen EasyShare camera bundle

BY Allison Cerra

ROCHESTER, N.Y. — Kodak has rolled out a limited-edition EasyShare camera bundle in partnership with Susan G. Komen for the Cure.

The Susan G. Komen Edition (C1530) camera bundle features a 14-megapixel camera with a 3x optical zoom and a Kodak Share Button in pink, as well as a slim camera case, 4GB memory card and wrist strap with pink ribbons. What’s more, $4 out of every purchase of the camera will be donated to Susan G. Komen for the Cure to help fight breast cancer.

"Kodak is pleased to offer a uniquely pink camera bundle in our first partnership with Susan G. Komen for the Cure during Breast Cancer Awareness Month," said Richard Ford, general manager for Kodak’s digital capture and accessories, Americas region. "Susan G. Komen is dedicated to raising awareness about this worthwhile cause and we are happy to team-up and get the word out to consumers with the launch of the EasyShare C1530 camera bundle."

The Kodak Susan G. Komen EasyShare camera bundle will carry a suggested retail price of $99.99 and will be available for a limited time on such retailer websites as Walmart.com, Kmart.com and more.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?